RPTX : Insider Transactions for Repare Therapeutics Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Repare Therapeutics Inc. (RPTX)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

36,750,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Repare Therapeutics is a precision medicine oncology company focused on the development of synthetic lethality (SL)-based therapies to patients with cancer. Using Co.'s SNIPRx platform, Co. is developing its pipeline of SL product candidates, including its primary product candidate, RP-3500, a potent and selective oral small molecule inhibitor of ATR (Ataxia-Telangiectasia and Rad3-related protein kinase) for the treatment of solid tumors with specific DNA damage repair-related genomic alterations, including those in the ATM gene (ataxia telangiectasia mutated kinase). Co. is also developing an inhibitor of polymerase theta, which is SL with multiple gene deficiencies found in tumors.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	1,227,301	1,227,301	3,633,420
Total Buy Value	$0	$6,249,889	$6,249,889	$33,578,038
Total People Bought	0	1	1	1
Total Buy Transactions	0	2	2	7
Total Shares Sold	21,690	21,690	32,163	2,532,163
Total Sell Value	$101,066	$101,066	$227,039	$31,793,364
Total People Sold	4	4	4	7
Total Sell Transactions	20	20	23	27
End Date	2024-01-28	2023-10-27	2023-04-28	2022-04-28

Adjust Filter Settings

Records found: 260

Page 1 of 11

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

EVP, CHIEF MEDICAL OFFICER

• – –

2024-04-01

4

AS

$4.66

$1,398

D/D

(300)

231,409

-

EVP, CHIEF FINANCIAL OFFICER

• – –

2024-04-01

4

AS

$4.61

$3,637

D/D

(789)

44,775

-

EVP, CHIEF SCIENTIFIC OFFICER

• – –

2024-04-01

4

AS

$4.66

$1,911

D/D

(410)

71,908

-

Segal Lloyd Mitchell

PRESIDENT AND CEO

• • –

2024-04-01

4

AS

$4.63

$11,533

I/I

(2,491)

107,558

-

EVP, CHIEF MEDICAL OFFICER

• – –

2024-03-28

4

AS

$4.64

$2,320

D/D

(500)

231,709

-

EVP, CHIEF FINANCIAL OFFICER

• – –

2024-03-28

4

AS

$4.62

$3,812

D/D

(825)

45,564

-

EVP, CHIEF SCIENTIFIC OFFICER

• – –

2024-03-28

4

AS

$4.64

$2,088

D/D

(450)

72,318

-

Segal Lloyd Mitchell

PRESIDENT AND CEO

• • –

2024-03-28

4

AS

$4.62

$12,243

I/I

(2,650)

110,049

-

EVP, CHIEF SCIENTIFIC OFFICER

• – –

2024-03-27

4

AS

$4.62

$2,079

D/D

(450)

72,768

-

EVP, CHIEF MEDICAL OFFICER

• – –

2024-03-27

4

AS

$4.62

$2,310

D/D

(500)

232,209

-

EVP, CHIEF FINANCIAL OFFICER

• – –

2024-03-27

4

AS

$4.62

$3,812

D/D

(825)

42,212

-

Segal Lloyd Mitchell

PRESIDENT AND CEO

• • –

2024-03-27

4

AS

$4.63

$12,270

I/I

(2,650)

83,866

-

EVP, CHIEF SCIENTIFIC OFFICER

• – –

2024-03-26

4

AS

$4.61

$2,075

D/D

(450)

73,218

-

EVP, CHIEF MEDICAL OFFICER

• – –

2024-03-26

4

AS

$4.60

$2,300

D/D

(500)

232,709

-

EVP, CHIEF FINANCIAL OFFICER

• – –

2024-03-26

4

AS

$4.60

$3,795

D/D

(825)

43,037

-

Segal Lloyd Mitchell

PRESIDENT AND CEO

• • –

2024-03-26

4

AS

$4.64

$12,296

I/I

(2,650)

86,516

-

EVP, CHIEF SCIENTIFIC OFFICER

• – –

2024-03-25

4

AS

$4.78

$2,151

D/D

(450)

73,668

-

EVP, CHIEF MEDICAL OFFICER

• – –

2024-03-25

4

AS

$4.78

$2,390

D/D

(500)

233,209

-

EVP, CHIEF FINANCIAL OFFICER

• – –

2024-03-25

4

AS

$4.79

$3,952

D/D

(825)

43,862

-

Segal Lloyd Mitchell

PRESIDENT AND CEO

• • –

2024-03-25

4

AS

$4.79

$12,694

I/I

(2,650)

89,166

-

EVP, CHIEF FINANCIAL OFFICER

• – –

2024-03-01

4

A

$0.00

$0

D/D

14,000

44,687

-

Segal Lloyd Mitchell

PRESIDENT AND CEO

• • –

2024-03-01

4

A

$0.00

$0

D/D

40,000

124,677

-

EVP, CHIEF SCIENTIFIC OFFICER

• – –

2024-03-01

4

A

$0.00

$0

D/D

14,000

74,118

-

EVP, CHIEF MEDICAL OFFICER

• – –

2024-03-01

4

A

$0.00

$0

D/D

14,000

233,709

-

EVP, Chief Medical Officer

• – –

2023-12-11

4

OE

$2.06

$98,755

D/D

43,746

219,709

-

260 Records found	1 2 3 4 5 6 7 8 9 Next	Page 1 of 11

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.